Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice. An in vitro study

BMC Neuroscience

Volumn 6, Issue , 2005, Pages

  Ogier, Crystel ^a   Creidy, Rita ^a   Boucraut, José ^a   Soloway, Paul D ^b   Khrestchatisky, Michel ^a   Rivera, Santiago ^a  

^a Mediterranée University   (France)

^b Plant Breeding and Genetics Section in the School of Integrative Plant Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FAS ANTIGEN; GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; THYMIDINE DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY; CCL2 PROTEIN, MOUSE; DIAGNOSTIC AGENT; FAS PROTEIN, MOUSE; GLIAL FIBRILLARY ACIDIC PROTEIN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; THYMIDINE; TRITIUM; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME DEFICIENCY; FLOW CYTOMETRY; GENOTYPE; IMMUNOREACTIVITY; IN VITRO STUDY; INFLAMMATION; MOUSE; MUTANT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; WILD TYPE; ZYMOGRAPHY; ANIMAL; BRAIN; CELL COUNT; CELL DEATH; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; METHODOLOGY; MOUSE MUTANT; NEWBORN; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; ANTIGENS, CD95; ASTROCYTES; BLOTTING, WESTERN; BRAIN; CELL COUNT; CELL DEATH; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL2; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTES; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR; TETRAZOLIUM SALTS; THIAZOLES; THYMIDINE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRITIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 29144526788     PISSN: 14712202     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-6-68     Document Type: Article

References (56)

1. Fawcett JW, Asher RA: The glial scar and central nervous system repair. Brain Res Bull 1999, 49:377-391.
2. Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RJ, Wong GG, Temple PA, Leary AC, Brown EL, et al: Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 1985, 315:768-771.
3. Bertaux B, Hornebeck W, Eisen AZ, Dubertret L: Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 1991, 97:679-685.
4. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992, 298:29-32.
5. Rivera S, Tremblay E, Timsit S, Canals O, Ben-Ari Y, Khrestchatisky M: Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response. J Neurosci 1997, 17:4223-4235.
6. Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL: Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 1998, 152:729-741.
7. Rivera S, Ogier C, Jourquin J, Timsit S, Szklarczyk AW, Miller K, Gearing AJ, Kaczmarek L, Khrestchatisky M: Gelatinase B and TIMP-1 are regulated in a cell-and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci 2002, 15:19-32.
8. Gottschall PE, Deb S: Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 1996, 3:69-75.
9. Bugno M, Witek B, Bereta J, Bereta M, Edwards DR, Kordula T: Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines. FEBS Lett 1999, 448:9-14.
10. Suryadevara R, Holter S, Borgmann K, Persidsky R, Labenz-Zink C, Persidsky Y, Gendelman HE, Wu L, Ghorpade A: Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia. Glia 2003, 44:47-56.
11. Lee WJ, Shin CY, Yoo BK, Ryu JR, Choi EY, Cheong JH, Ryu JH, Ko KH: Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide-stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2). Glia 2003, 41:15-24.
12. Giraudon P, Szymocha R, Buart S, Bernard A, Cartier L, Belin MF, Akaoka H: T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease. J Immunol 2000, 164:2718-2727.
13. Soloway PD, Alexander CM, Werb Z, Jaenisch R: Targeted mutagenesis of TIMP-1 reveals that lung tumor invasion is influenced by TIMP-1 genotype of the tumor but not by that of the host. Oncogene 1996, 13:2307-2314.
14. Nagata S: Fas ligand-induced apoptosis. Annu Rev Genet 1999, 33:29-55.
15. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP: Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999, 17:331-367.
16. Beyaert R, Van Loo G, Heyninck K, Vandenabeele P: Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas. Int Rev Cytol 2002, 214:225-272.
17. Wosik K, Becher B, Ezman A, Nalbantoglu J, Antel JP: Caspase 8 expression and signaling in Fas injury-resistant human fetal astrocytes. Glia 2001, 33:217-224.
18. Magnusson C, Vaux DL: Signalling by CD95 and TNF receptors: not only life and death. Immunol Cell Biol 1999, 77:41-46.
19. Becher B, Barker PA, Owens T, Antel JP: CD95-CD95L: can the brain learn from the immune system? Trends Neurosci 1998, 21:114-117.
20. Saas P, Walker PR, Quiquerez AL, Chalmers DE, Arrighi JF, Lienard A, Boucraut J, Dietrich PY: A self-defence mechanism of astrocytes against Fas-mediated death involving interleukin-8 and CXCR2. Neuroreport 2002, 13:1921-1924.
21. Becher B, D'Souza SD, Troutt AB, Antel JP: Fas expression on human fetal astrocytes without susceptibility to fas-mediated cytotoxicity. Neuroscience 1998, 84:627-634.
22. Saas P, Boucraut J, Quiquerez AL, Schnuriger V, Perrin G, Desplat-Jego S, Bernard D, Walker PR, Dietrich PY: CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation? J Immunol 1999, 162:2326-2333.
23. Lee SJ, Zhou T, Choi C, Wang Z, Benveniste EN: Differential regulation and function of Fas expression on glial cells. J Immunol 2000, 164:1277-1285.
24. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, et al.: Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 1994, 370:555-557.
25. Wetzel M, Rosenberg GA, Cunningham LA: Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis. Eur J Neurosci 2003, 18:1050-1060.
26. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K, Yagita H: Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995, 182:1777-1783.
27. Tanaka M, Itai T, Adachi M, Nagata S: Downregulation of Fas ligand by shedding. Nat Med 1998, 4:31-36.
28. Xia M, Xu C, Ji S, Xue S: Shedding of Fas ectodomain that affects apoptosis of hepatocytes occurring in regenerative liver. J Gastroenterol 2002, 37:1042-1047.
29. Lee SJ, Benveniste EN: Adhesion molecule expression and regulation on cells of the central nervous system. J Neuroimmunol 1999, 98:77-88.
30. Huang D, Han Y, Rani MR, Glabinski A, Trebst C, Sorensen T, Tani M, Wang J, Chien P, O'Bryan S, et al: Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev 2000, 177:52-67.
31. Saas P, Boucraut J, Walker PR, Quiquerez AL, Billot M, Desplat-Jego S, Chicheportiche Y, Dietrich PY: TWEAK stimulation of astrocytes and the proinflammatory consequences. Glia 2000, 32:102-107.
32. Dong Y, Benveniste EN: Immune function of astrocytes. Glia 2001, 36:180-190.
33. Lyons PD, Benveniste EN: Cleavage of membrane-associated ICAM-1 from astrocytes: involvement of a metalloprotease. Glia 1998, 22:103-112.
34. McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM: Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 2002, 100:1160-1167.
35. Penido C, Vieira-de-Abreu A, Bozza MT, Castro-Faria-Neto HC, Bozza PT: Role of monocyte chemotactic protein-1/CC chemokine ligand 2 on gamma delta T lymphocyte trafficking during inflammation induced by lipopolysaccharide or Mycobacterium bovis bacille Calmette-Guerin. J Immunol 2003, 171:6788-6794.
36. Babcock AA, Kuziel WA, Rivest S, Owens T: Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 2003, 23:7922-7930.
37. Nothnick WB, Soloway PD, Curry TE, Jr.: Pattern of messenger ribonucleic acid expression of tissue inhibitors of metalloproteinases (TIMPs) during testicular maturation in male mice lacking a functional TIMP-1 gene. Biol Reprod 1998, 59:364-370.
38. Jourquin J, Tremblay E, Bernard A, Charton G, Chaillan FA, Marchetti E, Roman FS, Soloway PD, Dive V, Yiotakis A, et al: Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Modulates Neuronal Death, Axonal Plasticity, and Learning and Memory. Eur J Neurosci In press.
39. Kitsberg D, Formstecher E, Fauquet M, Kubes M, Cordier J, Canton B, Pan G, Rolli M, Glowinski J, Chneiweiss H: Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci 1999, 19:8244-8251.
40. Gottschall PE, Yu X: Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 1995, 64:1513-1520.
41. Schonbeck U, Mach F, Libby P: Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 1998, 161:3340-3346.
42. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, Lipton SA: S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 2002, 297:1186-1190.
43. Jourquin J, Tremblay E, Decanis N, Charton G, Hanessian S, Chollet AM, Le Diguardher T, Khrestchatisky M, Rivera S: Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur J Neurosci 2003, 18:1507-1517.
44. Mannello F, Gazzanelli G: Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis 2001, 6:479-482.
45. Giraudon P, Malcus C, Chalon A, Vincent P, Khuth S, Bernard A, Belin MF: [Astrocytes, cells involved in neuro-immune interactions in the central nervous system]. J Soc Biol 2003, 197:103-112.
46. Ahonen M, Poukkula M, Baker AH, Kashiwagi M, Nagase H, Eriksson JE, Kahari VM: Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene 2003, 22:2121-2134.
47. Strand S, Vollmer P, van den Abeelen L, Gottfried D, Alla V, Heid H, Kuball J, Theobald M, Galle PR, Strand D: Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells. Oncogene 2004, 23:3732-3736.
48. Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RJ, Wong GG, Temple PA, Leary AC, Brown EL, et al.: Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 1985, 315:768-771.
49. Zhao WQ, Li H, Yamashita K, Guo XK, Hoshino T, Yoshida S, Shinya T, Hayakawa T: Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. J Cell Sci 1998, 111 ( Pt 9):1147-1153.
50. Apparailly F, Noel D, Millet V, Baker AH, Lisignoli G, Jacquet C, Kaiser MJ, Sany J, Jorgensen C: Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritis. Arthritis Rheum 2001, 44:1444-1454.
51. Seino K, Iwabuchi K, Kayagaki N, Miyata R, Nagaoka I, Matsuzawa A, Fukao K, Yagita H, Okumura K: Chemotactic activity of soluble Fas ligand against phagocytes. J Immunol 1998, 161:4484-4488.
52. Barnhart BC, Legembre P, Pietras E, Bubici C, Franzoso G, Peter ME: CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. Embo J 2004, 23:3175-3185.
53. Lyons PD, Benveniste EN: Cleavage of membrane-associated ICAM-1 from astrocytes: involvement of a metalloprotease. Glia 1998, 22:103-112.
54. Fiore E, Fusco C, Romero P, Stamenkovic I: Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene 2002; 21:5213-5223.
55. Otto VI, Gloor SM, Frentzel S, Gilli U, Ammann E, Hein AE, Folkers G, Trentz O, Kossmann T, Morganti-Kossmann MC: The production of macrophage inflammatory protein-2 induced by soluble intercellular adhesion molecule-1 in mouse astrocytes is mediated by src tyrosine kinases and p42/44 mitogen-activated protein kinase. J Neurochem 2002, 80:824-834.
56. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.